Organon & Co to buy Riovant’s arm Dermavant Sciences for $1.2 billion
US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.
US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.
The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.
Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.
Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a
Billionaire Bill Gates, who describes malnutrition as the “world’s worst child health crisis,” said in the next 25 years, about 40 million children will be
The Earth’s ozone layer may recover fully by 2040, and five years later over the Arctic, if the current policies restricting the production
HQ Team September 14, 2024: Erratic weather events due to global warming impact low-income groups is an established fact, but a new study
HQ Team September 14, 2024: High doses of Attention Deficit and Hyperactivity Disorder (ADHD) medicines can lead to a greater risk of developing
HQ Team September 13, 2024: More than 22,500 people, a quarter of those wounded in Gaza since Israel’s offensive began in October ’23,
HQ Team September 13, 2024: The U.S. Food and Drug Administration (FDA) has issued a safety warning about Veozah (fezolinetant), a medication prescribed